AtaiBeckley Inc's banner

AtaiBeckley Inc

@ataibeckley • 13,992 subscribers

Creating breakthroughs in mental health. $ATAI Founder & Chairman @C_Angermayer & CEO @SriniGRao

Shorts

#News: atai Life Sciences $ATAI & Beckley Psytech announce results from the open-label Phase 2a study of BPL-003 in treatment-resistant depression. Read more:

#News: atai Life Sciences $ATAI & Beckley Psytech announce results from the open-label Phase 2a study of BPL-003 in treatment-resistant depression. Read more:

112,639 views

#Q3 2025: a transformational quarter for AtaiBeckley! Highlights: ✅ BPL-003 received Breakthrough Therapy designation by the U.S. FDA for treatment-resistant depression ✅Reported positive Phase 2a and Phase 2b open-label extension data for BPL-003 Full update: #Q3 #Earnings

#Q3 2025: a transformational quarter for AtaiBeckley! Highlights: ✅ BPL-003 received Breakthrough Therapy designation by the U.S. FDA for treatment-resistant depression ✅Reported positive Phase 2a and Phase 2b open-label extension data for BPL-003 Full update: #Q3 #Earnings

10,808 views

#News: atai Life Sciences & Beckley Psytech have combined to form atai Beckley – Creating a global leader in psychedelic mental health therapies #mentalhealth therapies. Together, we’re accelerating innovation for those in need. Learn more: Join our conference call at 8am ET: #ataibeckley #Biotech

#News: atai Life Sciences & Beckley Psytech have combined to form atai Beckley – Creating a global leader in psychedelic mental health therapies #mentalhealth therapies. Together, we’re accelerating innovation for those in need. Learn more: Join our conference call at 8am ET: #ataibeckley #Biotech

11,601 views

Videos

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

#News: atai Life Sciences $ATAI & Beckley Psytech announce results from the open-label Phase 2a study of BPL-003 in treatment-resistant depression. Read more:

#News: atai Life Sciences $ATAI & Beckley Psytech announce results from the open-label Phase 2a study of BPL-003 in treatment-resistant depression. Read more:

AtaiBeckley Inc

112,639 views • 10 months ago

No more content to load